Skip to main content
profile image
Selected Works of Carlo B. Bifulco, M.D.
Article
MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies
Annals of Oncology (2018)
  • J. Galon, French Institute of Health and Medical Research
  • B. Mlecnik, French Institute of Health and Medical Research
  • F. Hermitte, R&D, HalioDx, Marseille, France
  • F. Marliot, Laboratory of Immunology, AP-HP, Georges Pompidou European Hospital, Paris, France
  • C. Bifulco, Providence Portland Medical Center
  • A. Lugli, University Hospital of Bern
  • I.D. Nagtegaal, Radboud University Nijmegen
  • A. Hartmann, Department of Surgery, University Erlangen-Nürnberg, Erlangen, Germany
  • M. van den Eynde, Department of Medical Oncology, Cliniques Universitaires St. Luc, Brussels, Belgium
  • M. Roehrl, Memorial Sloan Kettering Cancer Center
  • P. Ohashi, University Health Network
  • E. Zavadova, Charles University in Prague
  • T. Torigoe, Sapporo Medical University
  • P. Patel, Cancer Biology, The Gujarat Cancer & Research Institute, Ahmedabad, India
  • Y. Wang, Xi'an Jiaotong University
  • Y. Kawakami, Keio University
  • F.M. Marincola, AbbVie
  • P.A. Ascierto, Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori – I.R.C.C.S - Fondazione Pascale, Naples, Italy
  • B. Fox, Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute at the Robert W. Franz Cancer Center, Portland, OR, USA
  • F. Pagès, Laboratory of Immunology, AP-HP, Georges Pompidou European Hospital, Paris, France
Link
Disciplines
Publication Date
December 1, 2018
DOI
10.1093/ANNONC/MDY493.011
Citation Information
J. Galon, B. Mlecnik, F. Hermitte, F. Marliot, et al.. "MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies" Annals of Oncology Vol. 29 (2018)
Available at: http://works.bepress.com/carlo-bifulco/66/